New data on Helsinn’s oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022
June 02, 2022 08:30 ET | Helsinn Healthcare S.A.
New data on Helsinn’s oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022 Lugano, Switzerland, June 02, 2022 - Helsinn Group (“Helsinn”), a fully...
PDS Biotech Logo.png
PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101
June 02, 2022 08:00 ET | PDS Biotechnology Corporation
PDS Biotech has been granted Fast Track designation for PDS0101 in combination with KEYTRUDA® (pembrolizumab) for the treatment of recurrent or metastatic HPV16-positive head and neck cancer FLORHAM...
Health Gorilla and A
Health Gorilla and Apricity Health Join Forces to Improve Patient Care, Oncology Services
June 01, 2022 14:03 ET | Health Gorilla
Mountain View, California, June 01, 2022 (GLOBE NEWSWIRE) -- Health Gorilla, a leading Health Information Network (HIN) and interoperability provider, has announced a partnership with Apricity...
Avera Health and Sema4 Announce Data-driven Study to Advance Cancer Treatment Across the Avera Service Area
June 01, 2022 08:30 ET | Sema4
SIOUX FALLS, S.D. and STAMFORD, Conn., June 01, 2022 (GLOBE NEWSWIRE) -- Avera Health, an integrated regional health care system that serves 300 locations across the Upper Midwest, and Sema4...
Deep learning analysis of digital histopathology whole slide images
First CE-IVD marked AI solution for prognostic risk stratification of breast cancer patients.
June 01, 2022 03:59 ET | Stratipath
Stockholm, Sweden, June 01, 2022 (GLOBE NEWSWIRE) -- Stratipath, a global leader in AI-based precision diagnostic solutions, today announced that its AI software for prognostic risk stratification...
PDS Biotech Logo.png
PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
May 31, 2022 08:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 31, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer...
Compass Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
May 31, 2022 08:00 ET | Compass Therapeutics
BOSTON, May 31, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
NOVARTIS logo.jpg
FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
May 27, 2022 18:58 ET | Novartis Pharma AG
68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1 Sustained clinical benefit from Kymriah...
Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022, Demonstrating Encouraging Safety & Efficacy Profile
May 27, 2022 07:15 ET | Purple Biotech Ltd.
A Confirmed Partial Response in GEJ Patient, Stable Disease demonstrated in 75% of patients with mutated-KRAS colon cancer REHOVOT, Israel, May 27, 2022 (GLOBE NEWSWIRE) --...
Onconova Logo BLUE.jpg
Onconova Therapeutics Announces Abstract at the ASCO Annual Meeting Highlighting Narazaciclib’s Differentiated Inhibitory and Improved Safety Profile in Preclinical Models
May 26, 2022 17:10 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 26, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...